Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.691
-0.009 (-1.29%)
At close: Apr 28, 2026, 4:00 PM EDT
0.695
+0.004 (0.58%)
After-hours: Apr 28, 2026, 7:51 PM EDT
Tenaya Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 24.72 | 29.21 | 33.16 | 31.08 | 18.41 | |
| Research & Development | 68.61 | 86.74 | 98.04 | 94.54 | 54.39 | |
| Operating Expenses | 93.33 | 115.95 | 131.19 | 125.62 | 72.81 | |
| Operating Income | -93.33 | -115.95 | -131.19 | -125.62 | -72.81 | |
| Interest & Investment Income | 2.68 | 4.74 | 7.06 | 1.95 | 0.11 | |
| Other Non Operating Income (Expenses) | 0.05 | 0.08 | 0.05 | 0 | -0.02 | |
| EBT Excluding Unusual Items | -90.6 | -111.13 | -124.08 | -123.67 | -72.72 | |
| Pretax Income | -90.6 | -111.13 | -124.08 | -123.67 | -72.72 | |
| Net Income | -90.6 | -111.13 | -124.08 | -123.67 | -72.72 | |
| Net Income to Common | -90.6 | -111.13 | -124.08 | -123.67 | -72.72 | |
| Shares Outstanding (Basic) | 153 | 85 | 74 | 45 | 18 | |
| Shares Outstanding (Diluted) | 153 | 85 | 74 | 45 | 18 | |
| Shares Change (YoY) | 80.34% | 14.96% | 64.61% | 152.75% | 1724.33% | |
| EPS (Basic) | -0.59 | -1.31 | -1.68 | -2.76 | -4.10 | |
| EPS (Diluted) | -0.59 | -1.31 | -1.68 | -2.76 | -4.10 | |
| Free Cash Flow | -68.88 | -91.53 | -103.31 | -125.05 | -85.93 | |
| Free Cash Flow Per Share | -0.45 | -1.08 | -1.40 | -2.79 | -4.85 | |
| EBITDA | -84.9 | -107.48 | -122.51 | -119.15 | -69.85 | |
| D&A For EBITDA | 8.44 | 8.47 | 8.69 | 6.47 | 2.96 | |
| EBIT | -93.33 | -115.95 | -131.19 | -125.62 | -72.81 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.